NovoCure
NVCR
NVCR
265 hedge funds and large institutions have $3.78B invested in NovoCure in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 79 increasing their positions, 96 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
265
Holders Change
-28
Holders Change %
-9.56%
% of All Funds
4.18%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
31
Increased
79
Reduced
96
Closed
58
Calls
$103M
Puts
$43.8M
Net Calls
+$59.5M
Net Calls Change
-$33.9M
Top Buyers
Top Sellers
| 1 |
1
Capital World Investors
Los Angeles,
California
|
$473M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$102M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$5.2M |
| 4 |
4
BlackRock
New York
|
$337M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$5.52M |
